Skip to main content
main-content

Head and neck cancer

Head and neck cancer

27-09-2016 | Head and neck cancer | News | Article

Dalantercept monotherapy fails in refractory, metastatic SCCHN

A phase II trial of single-agent dalantercept in patients with platinum-refractory, recurrent or metastatic squamous cell carcinoma of the head and neck has failed to meet its primary efficacy endpoint, a US research team reports.

13-09-2016 | Head and neck cancer | News | Article

Detection bias may explain chronic sinusitis, HNC link

Elderly patients with chronic sinusitis have an elevated risk of developing certain head and neck cancers, but the risk is mostly confined to a short interval after sinusitis diagnosis, suggesting a role for detection bias or other artefacts, say US researchers.

31-03-2016 | Head and neck cancer | News | Article

Non-HPV-16 genotypes linked to poor HNSCC survival

Patients with head and neck squamous cell carcinoma who harbour human papillomavirus genotypes other than HPV-16 have significantly worse overall survival than those testing positive for HPV-16, suggests an analysis of The Cancer Genome Atlas data.

25-11-2015 | Head and neck cancer | News | Article

Improved survival in HPV-positive oropharyngeal cancer patients confirmed

A large population-based study has confirmed the association between the presence of human papillomavirus DNA in oropharyngeal squamous cell cancer and improved patient survival.

08-05-2015 | Head and neck cancer | News | Article

Chemotherapy benefit in nasopharyngeal carcinoma confirmed

Addition of chemotherapy to radiotherapy significantly improves outcomes in patients with nonmetastatic nasopharyngeal carcinoma, shows a meta-analysis.

Image Credits